Key facts
- Lutra Health’s last known valuation is $5.2M (Jun 2025).
- It has raised $1.7M; the latest was Early Stage VC ($1.1M) in Jun 2025.
- Notable investors include The FSE Group, Development Bank of Wales, QantX.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Lutra Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Lutra Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lutra Health
Developer of an eyecare platform designed to connect patients, optometrists, and eye surgeons. The company's platform facilitates communication and streamlines the referral and treatment process in ophthalmology, integrates with electronic health records, enabling patients to access educational content, and supports healthcare professionals in managing surgical workflows.
- Sector
- Healthcare
- HQ
- Pencoed, United Kingdom
- Founded
- 2021
- Employees
- 10
- Website
- lutrahealth.com/
- Ownership
- Privately Held (backing)
Lutra Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lutra Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lutra Health in its N-PORT filings yet. We sweep new filings monthly.